JP2004189753A5 - - Google Patents

Download PDF

Info

Publication number
JP2004189753A5
JP2004189753A5 JP2004062679A JP2004062679A JP2004189753A5 JP 2004189753 A5 JP2004189753 A5 JP 2004189753A5 JP 2004062679 A JP2004062679 A JP 2004062679A JP 2004062679 A JP2004062679 A JP 2004062679A JP 2004189753 A5 JP2004189753 A5 JP 2004189753A5
Authority
JP
Japan
Prior art keywords
composition
fatty acid
acid esters
mono
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004062679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004189753A (ja
Filing date
Publication date
Priority claimed from GBGB9804742.6A external-priority patent/GB9804742D0/en
Priority claimed from GBGB9805104.8A external-priority patent/GB9805104D0/en
Priority claimed from GBGB9805199.8A external-priority patent/GB9805199D0/en
Application filed filed Critical
Publication of JP2004189753A publication Critical patent/JP2004189753A/ja
Publication of JP2004189753A5 publication Critical patent/JP2004189753A5/ja
Pending legal-status Critical Current

Links

JP2004062679A 1998-03-06 2004-03-05 サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物 Pending JP2004189753A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9804742.6A GB9804742D0 (en) 1998-03-06 1998-03-06 Organic compounds
GBGB9805104.8A GB9805104D0 (en) 1998-03-10 1998-03-10 Organic compounds
GBGB9805199.8A GB9805199D0 (en) 1998-03-11 1998-03-11 Organic compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000534187A Division JP2002505271A (ja) 1998-03-06 1999-03-04 サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物

Publications (2)

Publication Number Publication Date
JP2004189753A JP2004189753A (ja) 2004-07-08
JP2004189753A5 true JP2004189753A5 (https=) 2009-04-23

Family

ID=27269231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000534187A Withdrawn JP2002505271A (ja) 1998-03-06 1999-03-04 サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物
JP2004062679A Pending JP2004189753A (ja) 1998-03-06 2004-03-05 サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000534187A Withdrawn JP2002505271A (ja) 1998-03-06 1999-03-04 サイクロスポリン類またはマクロライド含有エマルジョン前濃縮物

Country Status (29)

Country Link
EP (2) EP1354582A3 (https=)
JP (2) JP2002505271A (https=)
KR (1) KR100443306B1 (https=)
CN (1) CN1195495C (https=)
AR (1) AR015729A1 (https=)
AT (1) ATE277599T1 (https=)
AU (1) AU749217B2 (https=)
BE (3) BE1012400A5 (https=)
BR (1) BR9908597A (https=)
CA (1) CA2322845C (https=)
CO (1) CO4930289A1 (https=)
CZ (1) CZ301967B6 (https=)
DE (2) DE19983012T1 (https=)
ES (1) ES2228014T3 (https=)
FR (4) FR2775596B1 (https=)
GB (1) GB2350791B (https=)
HU (1) HUP0101080A3 (https=)
ID (1) ID25908A (https=)
IL (2) IL138248A0 (https=)
IT (1) IT1313550B1 (https=)
MY (1) MY129274A (https=)
NO (1) NO331800B1 (https=)
NZ (1) NZ506644A (https=)
PE (1) PE20000324A1 (https=)
PT (1) PT1059913E (https=)
SK (1) SK285139B6 (https=)
TR (1) TR200002586T2 (https=)
TW (3) TWI248368B (https=)
WO (1) WO1999044584A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1236813C (zh) * 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
EP1154759B1 (en) * 1998-12-30 2008-08-13 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
AU1043201A (en) * 1999-11-02 2001-05-14 Cipla Limited Cyclosporin formulation
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2003002095A1 (fr) * 2001-06-28 2003-01-09 Chugai Seiyaku Kabushiki Kaisha Preparation d'une micro-emulsion de type huile-eau
US6960563B2 (en) 2001-08-31 2005-11-01 Morton Grove Pharmaceuticals, Inc. Spontaneous emulsions containing cyclosporine
GB2391471B (en) * 2002-08-02 2005-05-04 Satishchandra Punambhai Patel Pharmaceutical compositions
KR20040047056A (ko) * 2002-11-29 2004-06-05 한미약품 주식회사 비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
KR20040084240A (ko) * 2003-03-27 2004-10-06 (주) 코스메디 고형지질나노입자, 이를 함유하는 활성성분 전달용약학조성물 및 이의 제조방법
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
CA2578854A1 (en) * 2004-10-29 2006-05-11 Novartis Ag Spontaneously dispersible pharmaceutical compositions
MX2007011250A (es) * 2005-03-21 2007-11-14 Ivax Pharmaceuticals Sro Inhibidor de la cristalizacion y su uso en capsulas de gelatina.
CN101032620B (zh) * 2007-03-08 2010-05-19 上海凯昭医药科技有限公司 一种环孢素自乳化制剂及其制备方法
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
WO2009117151A2 (en) 2008-03-20 2009-09-24 Virun, Inc. Compositions containing non-polar compounds
MX2010010050A (es) 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP5567909B2 (ja) * 2010-06-17 2014-08-06 東洋カプセル株式会社 タクロリムス含有カプセル剤
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
WO2014106048A2 (en) 2012-12-31 2014-07-03 Jrx Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
KR101458466B1 (ko) * 2013-06-24 2014-11-07 한국화학연구원 면역억제제가 봉입된 마이셀을 함유하는 경구제
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
KR20180053318A (ko) 2015-09-17 2018-05-21 제이알엑스 바이오테크놀로지, 인코포레이티드 피부 수화 또는 보습을 향상시키기 위한 접근법
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
AU2019308326B2 (en) 2018-07-20 2025-07-31 Lipocine Inc. Liver disease
EP3886813B1 (en) * 2018-11-26 2023-03-22 Hepion Pharmaceuticals, Inc. Pharmaceutical formulations of cyclosporine analogs
WO2024014959A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Micelle-generating formulations with improved hydrophobicity
WO2024014958A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Lides formulation platform
CN117797093A (zh) * 2024-02-29 2024-04-02 中国农业科学院农业环境与可持续发展研究所 一种以大环内酯类药物为活性成分的兽用口服纳米液体制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
EP1142568A1 (en) * 1992-09-25 2001-10-10 Novartis AG Pharmaceutical compositions containing cyclosporins
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
WO1995022343A1 (en) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
JP3131112B2 (ja) * 1994-02-17 2001-01-31 株式会社資生堂 シクロスポリン含有乳化組成物
ATE299017T1 (de) * 1994-10-26 2005-07-15 Novartis Pharma Gmbh Arzneimittel
PE52896A1 (es) * 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil

Similar Documents

Publication Publication Date Title
JP2004189753A5 (https=)
RU2143919C1 (ru) Фармацевтическая композиция, продукт трансэтерификации кукурузного масла глицерином и способ его получения
KR0167696B1 (ko) 사이클로스포린-함유 연질캅셀제 조성물
RU2257917C2 (ru) Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
CA2322845A1 (en) Emulsion preconcentrates containing cyclosporin or a macrolide
DE60019100T2 (de) Im wesentlichen ölfreie cyclosporin zusammensetzungen
RU2246296C2 (ru) Композиция, включающая ундеканоат тестостерона и касторовое масло
TWI240636B (en) Spontaneously dispersible pharmaceutical containing n-benzoyl-staurosporine and the use thereof
HU225535B1 (en) Microemulsion pre-concentrate and microemulsion
KR20030066781A (ko) 친지성 유효성분을 포함하는 미셀 콜로이드상의 약제학적조성물
CZ301382B6 (cs) Hydrofilní binární systémy pro podávání cyklosporinu
KR101025641B1 (ko) 매스틱 자가유화에멀젼 조성물 및 이를 함유하는 캡슐
HUP0202737A2 (hu) Lipáz inhibítorokat tartalmazó diszperziós készítmények
JP2005513096A (ja) シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物
JPH11100326A (ja) 軟質ゼラチンカプセル剤
KR20000016761A (ko) 사이클로스포린-함유 연질캅셀제
US20100035949A1 (en) Microemulsion dosage forms of valsartan and methods of making the same
KR20050083607A (ko) 시클로스포린을 포함하는 경구용 약학적 조성물
KR101928589B1 (ko) 알리스포리비르를 포함하는 제약 조성물
CN1717219B (zh) 用于联苯二甲双酯口服给药的微乳组合物
JP2007509136A (ja) ビフェニルジメチルジカルボキシレート及びシリビンを含む経口用マイクロエマルション組成物
AU741923B2 (en) Pharmaceutical compositions
KR100525234B1 (ko) 사이클로스포린 함유 연질캅셀제 및 그 제조방법
RU2000125560A (ru) Предварительно приготовленные эмульсионные концентраты, содержащие циклоспорин или макролид
JP2005075804A (ja) メナテトレノン含有医薬組成物